Cargando…
The Meaning and Reliability of Minimal Important Differences (MIDs) for Clinician-Reported Outcome Measures (ClinROMs) in Dermatology—A Scoping Review
Background: Clinician-reported outcome measures (ClinROMs) are frequently used in clinical trials and daily practice to evaluate the disease status and evolution of skin disorders. The minimal important difference (MID) represents the smallest difference that decreases the disease impact enough to m...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9321211/ https://www.ncbi.nlm.nih.gov/pubmed/35887664 http://dx.doi.org/10.3390/jpm12071167 |
_version_ | 1784755982546501632 |
---|---|
author | Speeckaert, Reinhart Belpaire, Arno Herbelet, Sandrine Speeckaert, Marijn M. van Geel, Nanja |
author_facet | Speeckaert, Reinhart Belpaire, Arno Herbelet, Sandrine Speeckaert, Marijn M. van Geel, Nanja |
author_sort | Speeckaert, Reinhart |
collection | PubMed |
description | Background: Clinician-reported outcome measures (ClinROMs) are frequently used in clinical trials and daily practice to evaluate the disease status and evolution of skin disorders. The minimal important difference (MID) represents the smallest difference that decreases the disease impact enough to make a treatment change worthwhile for patients. As no clear guidance exists on the preferred method to calculate MIDs for ClinROMs, we evaluated how the published values for different skin disorders should be interpreted. Methods: A systematic search was performed for MIDs of ClinROMs that focus on skin disorders and/or symptoms. The results of the questions in the credibility instrument for MIDs of Devji et al., 2020 were analyzed to gain insights into the meaning of these MIDs. Results: 29 MIDs were identified. The most common skin diseases were atopic dermatitis/eczema, followed by bullous disorders and psoriasis. A minimal important difference from the patients’ perspective was determined in 31% of the cases. However, in 41.4% of the cases, it concerned a substantial rather than a minimal difference in disease severity rated by physicians. Over half (55.1%) of the studies contained an inadequate number of patients (n < 150). MID values increased substantially in patients with severe compared to mild disease. Conclusions: MIDs of ClinROMs for skin disorders should be carefully interpreted due to the substantial differences in methodology between the studies. There is an urgent need for a consensus method to report reliable MIDs. Otherwise, this lack of uniformity could not only affect the design and conclusion of clinical trials but also skew treatment decisions. |
format | Online Article Text |
id | pubmed-9321211 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-93212112022-07-27 The Meaning and Reliability of Minimal Important Differences (MIDs) for Clinician-Reported Outcome Measures (ClinROMs) in Dermatology—A Scoping Review Speeckaert, Reinhart Belpaire, Arno Herbelet, Sandrine Speeckaert, Marijn M. van Geel, Nanja J Pers Med Review Background: Clinician-reported outcome measures (ClinROMs) are frequently used in clinical trials and daily practice to evaluate the disease status and evolution of skin disorders. The minimal important difference (MID) represents the smallest difference that decreases the disease impact enough to make a treatment change worthwhile for patients. As no clear guidance exists on the preferred method to calculate MIDs for ClinROMs, we evaluated how the published values for different skin disorders should be interpreted. Methods: A systematic search was performed for MIDs of ClinROMs that focus on skin disorders and/or symptoms. The results of the questions in the credibility instrument for MIDs of Devji et al., 2020 were analyzed to gain insights into the meaning of these MIDs. Results: 29 MIDs were identified. The most common skin diseases were atopic dermatitis/eczema, followed by bullous disorders and psoriasis. A minimal important difference from the patients’ perspective was determined in 31% of the cases. However, in 41.4% of the cases, it concerned a substantial rather than a minimal difference in disease severity rated by physicians. Over half (55.1%) of the studies contained an inadequate number of patients (n < 150). MID values increased substantially in patients with severe compared to mild disease. Conclusions: MIDs of ClinROMs for skin disorders should be carefully interpreted due to the substantial differences in methodology between the studies. There is an urgent need for a consensus method to report reliable MIDs. Otherwise, this lack of uniformity could not only affect the design and conclusion of clinical trials but also skew treatment decisions. MDPI 2022-07-18 /pmc/articles/PMC9321211/ /pubmed/35887664 http://dx.doi.org/10.3390/jpm12071167 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Speeckaert, Reinhart Belpaire, Arno Herbelet, Sandrine Speeckaert, Marijn M. van Geel, Nanja The Meaning and Reliability of Minimal Important Differences (MIDs) for Clinician-Reported Outcome Measures (ClinROMs) in Dermatology—A Scoping Review |
title | The Meaning and Reliability of Minimal Important Differences (MIDs) for Clinician-Reported Outcome Measures (ClinROMs) in Dermatology—A Scoping Review |
title_full | The Meaning and Reliability of Minimal Important Differences (MIDs) for Clinician-Reported Outcome Measures (ClinROMs) in Dermatology—A Scoping Review |
title_fullStr | The Meaning and Reliability of Minimal Important Differences (MIDs) for Clinician-Reported Outcome Measures (ClinROMs) in Dermatology—A Scoping Review |
title_full_unstemmed | The Meaning and Reliability of Minimal Important Differences (MIDs) for Clinician-Reported Outcome Measures (ClinROMs) in Dermatology—A Scoping Review |
title_short | The Meaning and Reliability of Minimal Important Differences (MIDs) for Clinician-Reported Outcome Measures (ClinROMs) in Dermatology—A Scoping Review |
title_sort | meaning and reliability of minimal important differences (mids) for clinician-reported outcome measures (clinroms) in dermatology—a scoping review |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9321211/ https://www.ncbi.nlm.nih.gov/pubmed/35887664 http://dx.doi.org/10.3390/jpm12071167 |
work_keys_str_mv | AT speeckaertreinhart themeaningandreliabilityofminimalimportantdifferencesmidsforclinicianreportedoutcomemeasuresclinromsindermatologyascopingreview AT belpairearno themeaningandreliabilityofminimalimportantdifferencesmidsforclinicianreportedoutcomemeasuresclinromsindermatologyascopingreview AT herbeletsandrine themeaningandreliabilityofminimalimportantdifferencesmidsforclinicianreportedoutcomemeasuresclinromsindermatologyascopingreview AT speeckaertmarijnm themeaningandreliabilityofminimalimportantdifferencesmidsforclinicianreportedoutcomemeasuresclinromsindermatologyascopingreview AT vangeelnanja themeaningandreliabilityofminimalimportantdifferencesmidsforclinicianreportedoutcomemeasuresclinromsindermatologyascopingreview AT speeckaertreinhart meaningandreliabilityofminimalimportantdifferencesmidsforclinicianreportedoutcomemeasuresclinromsindermatologyascopingreview AT belpairearno meaningandreliabilityofminimalimportantdifferencesmidsforclinicianreportedoutcomemeasuresclinromsindermatologyascopingreview AT herbeletsandrine meaningandreliabilityofminimalimportantdifferencesmidsforclinicianreportedoutcomemeasuresclinromsindermatologyascopingreview AT speeckaertmarijnm meaningandreliabilityofminimalimportantdifferencesmidsforclinicianreportedoutcomemeasuresclinromsindermatologyascopingreview AT vangeelnanja meaningandreliabilityofminimalimportantdifferencesmidsforclinicianreportedoutcomemeasuresclinromsindermatologyascopingreview |